Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-small Cell Lung Cancer · Consolidation Immunotherapy · Radiotherapy or Sequential Chemoradiation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Cancer Hospital and Institute, Beijing, China
Contact: Study coordinator (Rong Yu, MD) · yurong311@aliyun.com · 13501147200
Contact: Study coordinator (Wei Deng, MD) · sherrydw@126.com · 18813019080

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Non-Small Cell Lung Cancer · Exercise Training · Immunotherapy

Abroad (travel likely)Recruiting

Graz, Austria

Efficacy and Safety of Super-hyperfractionation Pulse Radiotherapy Combined With ICIs for Advanced NSCLC

Lung Cancer · Immune Checkpoint Inhibitor · Radiotherapy

Abroad (travel likely)Recruiting

Chongqing, China · Chongqing, China

Postoperative Radiotherapy for Postoperative N2 Metastases of NSCLC in the Immunotherapy Era (Phase II)

Non-Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE4

Fuzhou, China

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States